Particle.news
Download on the App Store

ENEM 2025 Question Highlights Gila Monster’s Role in Ozempic’s Origins

Reports explain the exam used the species to illustrate the biology behind GLP-1 medicines such as Ozempic.

Overview

  • On the second test day, the ENEM included an item on Heloderma suspectum that linked its digestive traits and venom to the mechanism of GLP-1 drugs.
  • Teachers say the question assessed adaptation concepts by asking students to identify the Brazilian biome analogous to the lizard’s desert habitat.
  • According to Instituto Butantan, the reptile eats birds, small lizards, rodents, and eggs, can consume up to half its body weight at once, and may go months without feeding.
  • The species lives in arid and semi-arid regions, shelters in burrows during hot months, hibernates in winter, is native to northwestern Mexico and the U.S. Southwest, and is not found in Brazil.
  • Scientists identified exendin-4 in the animal’s venom, a discovery that enabled GLP-1 therapies; Ozempic treats type 2 diabetes and is widely associated with weight loss, while the lizard’s bite can cause complications in humans.